Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin/Metronidazole vs. Piperacillin/Tazobactam for Complicated Appendicitis
NCT00236912Phase 4Terminated
- Sponsor
- Johnson & Johnson
- Start
- Jul 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of levofloxacin and metronidazole in appendicitis (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Clinical success at the post-therapy visit and Safety by adverse events. Started Jul 2003; status: terminated.
02
Drugs
levofloxacinmetronidazole
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT00236912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236912.